Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AAV-based Gene Therapy
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Rentschler Biopharma
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the agreement, Rentschler Biopharma’s ATMP site will support the bioprocess development of AAV material for planned pre-clinical testing of Ikarovec’s novel AAV-based therapy for the treatment of geographic atrophy.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
June 01, 2023
Lead Product(s) : AAV-based Gene Therapy
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Rentschler Biopharma
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?